This is a "connection" page, showing publications co-authored by Atman P. Shah and Valluvan Jeevanandam.
Left Ventricular Assist Device Deactivation via Percutaneous Closure of the Outflow Graft. J Card Fail. 2016 Aug; 22(8):653-5.
Sequential Organ Failure Assessment Score at Presentation Predicts Survival in Patients Treated With Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation. J Invasive Cardiol. 2016 Apr; 28(4):133-8.
Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency. Catheter Cardiovasc Interv. 2016 Apr; 87(5):971-9.
Successful percutaneous trans-catheter treatment of left ventricular assist device outflow graft stenosis with a covered stent. ESC Heart Fail. 2015 Jun; 2(2):100-102.
Successful use of ECMO in a Jehovah's Witness after complicated re-heart transplant. ASAIO J. 2013 Sep-Oct; 59(5):528-9.
Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics. JACC Cardiovasc Interv. 2013 Jan; 6(1):84-9.
Percutaneous transcatheter closure of the aortic valve to treat cardiogenic shock in a left ventricular assist device patient with severe aortic insufficiency. Ann Thorac Surg. 2012 Sep; 94(3):985-8.
Percutaneous transcatheter closure of the native aortic valve to treat de novo aortic insufficiency after implantation of a left ventricular assist device. JACC Cardiovasc Interv. 2012 Mar; 5(3):358-9.
PCI in Patients Supported With CF-LVADs: Indications, Safety, and Outcomes. J Invasive Cardiol. 2016 Jun; 28(6):238-42.
Prophylactic Subclavian Artery Intraaortic Balloon Counter-Pulsation is Safe in High-Risk Cardiac Surgery Patients. ASAIO J. 2015 Sep-Oct; 61(5):e36-9.
Prophylactic subclavian artery intra-aortic balloon counter-pulsation is safe in high-risk cardiac surgery patients. ASAIO J. 2015 Apr 23.